Phil Fang Cheng

26PUBLICATIONS
210CO-AUTHORS
Predictive and prognostic markersAutonomic nervous systemMolecular targetsBiomaterialsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 05, 2026
The Virtual Tissues foundation model resolves spatial proteomics across scales.

|Jun 26, 2025
Uncovering the Distinct Role of Phleum p 4 in Grass Pollen Allergy: Sensitization Patterns in 1963 Swiss Patients.

Patrick Frey, Phil Cheng, Peter Schmid-Grendelmeier

|Apr 17, 2025
Protein Kinase C Inhibition Overcomes Targeted Therapy Resistance in Cutaneous Melanoma.

Corinne I Stoffel, Ossia Eichhoff, Phil F Cheng

|Jan 28, 2025
Human Dermal Microvascular Arterial and Venous Blood Endothelial Cells and Their Use in Bioengineered Dermo-Epidermal Skin Substitutes.

Dominic Rütsche, Monica Nanni, Phil Cheng

|Nov 09, 2024
Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe.

Michael Weichenthal, Joanna Mangana, Iva Gavrilova

|Aug 29, 2024
A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma.

Florentia Dimitriou, Phil F Cheng, Annalisa Saltari

Pageof 5

Frequent Collaborators

14 joint publications

Reinhard Dummer

11 joint publications

Mitchell Paul Levesque

5 joint publications

Ossia M Eichhoff

4 joint publications

Patrick Turko